Singapore-based biomedical company, Moleac, and SGX-listed China Healthcare Limited, announced a collaboration to offer a more comprehensive treatment to aid speedy recovery for stroke patients.

The treatment comes in the form of Neuroaid, a traditional Chinese medicine which obtained listing as a Chinese Proprietary Medicine from the Health Sciences Authority of Singapore earlier this year with the indication to support neurological functions. The collaboration reflects a growing trend where traditional medicine is used in combination with western medicine for the treatment and management of a wide range of diseases.

Stroke patients account for a large number of patients treated at China Healthcare's seven Econ Medicare Centres and Nursing Homes. Of its approximately 1,000-beds, 20% are dedicated to patients recovering from stroke. It is also the only healthcare provider in Singapore to have its own in-house Traditional Chinese Medicine clinic and physicians, specializing in stroke rehabilitation.

Marketed internationally by Moleac, Neuroaid is developed from natural ingredients and has benefited around half a million stroke patients in China. From clinical trials performed with 800 patients in China, Neuroaid has shown high levels of safety and efficacy in improving stroke rehabilitation.

Neuroaid will soon be available at all China Healthcare's Econ Medicare Centres, Nursing Homes and West Point Hospital and stroke patients will be advised by their treating TCM physician on how to incorporate it in their stroke recovery package.

Source:佚名